Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study
NCT ID: NCT06470893
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2024-09-23
2025-07-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing the Acceptability of Psychological Treatments for Obsessive-compulsive Disorder
NCT03661905
Mechanisms of Exposure Therapy for OCD
NCT06173752
Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
NCT04701372
Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
NCT00000386
Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms
NCT02635178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OCD-NET Group
Participants will receive the OCD-NET intervention for up to 12 months.
OCD-NET
OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD. OCD-NET is a self-paced intervention that participants complete entirely online with the support of an assigned individual therapist. Most participants complete this treatment in up to twelve weeks. On average, participants are expected to spend between one to five hours per week during the first half of treatment. In the second half of treatment when participants begin regular exposure and response prevention (ERP) exercises, participants are expected to spend about one hour per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCD-NET
OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD. OCD-NET is a self-paced intervention that participants complete entirely online with the support of an assigned individual therapist. Most participants complete this treatment in up to twelve weeks. On average, participants are expected to spend between one to five hours per week during the first half of treatment. In the second half of treatment when participants begin regular exposure and response prevention (ERP) exercises, participants are expected to spend about one hour per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Located within the United States
* 18-90 years old
* Able to provide consent
* Current diagnosis of OCD as assessed by clinical interview
Exclusion Criteria
* Individuals who are not yet adults (infants, children, teenagers)
* Participants currently located outside of the United States
* Prisoners
* Participants with hoarding as the primary OCD symptom
* Severe mental illness (e.g. schizophrenia, substance abuse); organic brain syndrome; or serious, current suicidal/homicidal ideation (based on phone screening or initial assessment)
* Concurrent enrollment in another psychotherapy treatment
* Participants taking psychotropic medication may be excluded if:
* They have started a brand new psychotropic medication within the last 12 weeks
* They have changed the dose of their psychotropic medication within the last 4 weeks
* They anticipate that they cannot maintain the current dose of their psychotropic medication for the duration of the study
* Participants may be excluded if they have any cognitive or physical impairments that would interfere with their participation (e.g., significant head injury, cognitive disability, dementia).
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kiara Timpano
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kiara Timpano, PhD
Role: STUDY_CHAIR
University of Miami
Amelia Dev, MS
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20240483
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.